Posted inClinical Trials, In the Pipeline, Neuroscience Treating Parkinson’s Disease: Betting on Alpha-Synuclein by Mark Gubar and Julia Mardi January 14, 2022April 11, 2024 The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.
